Ambergen, Inc. announced that it will issue 45,914 series C preferred shares at an issue price of $108.899246 per share for the gross proceeds of $4,999,999.980844 on March 22, 2022. The preferred shares will be convertible into common shares at a fixed conversion price $108.89924 per share. The company will issue securities pursuant to exemption provided under Regulation D. The minimum investment accepted from any outside investor is $5,000,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
77.76 USD | -1.02% | -11.21% | +5.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.82% | 10.82B | |
+2.64% | 207B | |
+1.80% | 175B | |
+8.59% | 132B | |
+16.47% | 99.1B | |
-3.42% | 60.89B | |
+12.71% | 52.04B | |
-6.61% | 45.48B | |
-4.53% | 38.81B | |
+9.27% | 38.77B |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- AmberGen, Inc. announced that it expects to receive $5 million in funding